Cooperative Agreement U01CE003820
Award Date 9/30/25
Completion Date 9/29/28
Dollars Obligated $350K
Funding Federal Agency
Awarding Federal Agency
Awardee
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
Washington, USA
Similar Awards
- This federal Cooperative Agreement award of $349,997, provided by the Centers for Disease Control and Prevention's National Center for Injury Prevention and Control under the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136), supports the Regents of the University of Minnesota's efforts to expand access to low-barrier buprenorphine in acute care settings. The project aims to enhance best practice model fidelity and implement prehospital innovations to...
- This Cooperative Agreement award for $348,837 was granted by the Centers for Disease Control and Prevention's National Center for Injury Prevention and Control under the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136). The award supports research by The General Hospital Corporation (Massachusetts General Hospital) on the effects of high-dose medications for opioid use disorder on treatment retention, drug use patterns, and overdose risks amidst the...
- This $349,894 Cooperative Agreement award, made on September 30, 2025 by the Centers for Disease Control and Prevention's National Center for Injury Prevention and Control under the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136) federal grant program, aims to assess the effectiveness of Screening, Brief Intervention, and Referral to Treatment (SBIRT) to reduce polysubstance impaired driving among emerging adults aged 18-30 in Washington State. The...
- This $350,000 Cooperative Agreement award was provided by the Centers for Disease Control and Prevention's National Center for Injury Prevention and Control under the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136) on September 30, 2025. The award will support research and coordination to expand access to Medications for Opioid Use Disorder (MOUD) for patients in emergency departments over a 4-year period through September 29, 2029. The University of...
- This federal Cooperative Agreement award, titled "ENHANCING PROJECT DHARMA; EVALUATING A COMMUNITY-BASED DRUG CHECKING NAVIGATOR INTERVENTION TO PREVENT OVERDOSES", is funded by the Centers for Disease Control and Prevention's Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136). The $700,000 award, granted on Sep 30, 2025, supports Mainehealth, a non-profit healthcare system based in Portland, Maine, in developing and evaluating a community-based...
- The federal Cooperative Agreement award CE25-149, "ENGAGING OVERDOSE SURVIVORS WITH THE SAFESPOT HOTLINE FOR SECONDARY OVERDOSE PREVENTION", is funded by the Centers for Disease Control and Prevention's (CDC) Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136). The $698,150 award, granted to the Boston Medical Center Corporation (BMC), aims to develop and implement an intervention that engages overdose survivors with the SafeSpot hotline for...
- This Cooperative Agreement award, totaling $341,020.00, was provided by the Centers for Disease Control and Prevention's Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136) to evaluate the impact of a publicly funded partial hospitalization program in reducing overdose risk in Philadelphia. The award was made to the Public Health Management Corporation (PHMC), a non-profit health and social service organization based in Philadelphia. The project period...
- The University of Washington received a $777,497 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) to conduct a hybrid implementation-effectiveness study of a pharmacist-led collaborative care model to improve access to hepatitis C treatment for people who use drugs with housing insecurity. The 5-year project aims to evaluate the reach, adoption, effectiveness, and maintenance of the "Pharmacist, Physician, Patient...
- This Cooperative Agreement award, CE25-149, was provided by the Centers for Disease Control and Prevention's (CDC) Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136). The $349,258 grant was awarded to the University of North Carolina at Chapel Hill (UNC-CH) on September 30, 2025 for a project period ending on September 29, 2028. The grant will fund research on the effect of Medicaid expansion on medications for opioid use disorder, mental health care, and...
- This Cooperative Agreement award from the Centers for Disease Control and Prevention's Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136) provides $699,911 in funding to The Johns Hopkins University to conduct a Randomized Clinical Trial of a Peer Education Intervention to Promote Social Diffusion of Overdose Prevention and Drug Use Cessation in High Burden Communities. The project period is from Sep 30, 2025 to Sep 29, 2030. The goal of the research is...